บุคลากรคณะวิทยาศาสตร์

← สาขาวิทยาศาสตร์สุขภาพและวิทยาศาสตร์ประยุกต์
ผศ.ดร.

สุมาลี อบเชย

ผู้ช่วยศาสตราจารย์
Fellow (UKPSF)
พี่เลี้ยง UKPSF
  • sumalee.o@psu.ac.th
  • 8270
  • ชีวเคมี
  • สาขาวิทยาศาสตร์สุขภาพและวิทยาศาสตร์ประยุกต์

ประวัติการศึกษา

ปีที่สำเร็จการศึกษา
วุฒิการศึกษา
ประเทศ
2554
ปร.ด. (ชีวเคมีทางการแพทย์) มหาวิทยาลัยขอนแก่น
ไทย
2549
วท.บ. (เทคนิคการแพทย์) มหาวิทยาลัยขอนแก่น
ไทย

Publication

ฐานข้อมูล Scopus

Author ID: 35503734500
1
Maskaew S., Meethong M., Puechpon P., Phupet B., Madsari N., Obchoei S., Utarabhand P., Runsaeng P., 2025. Functional characterization of calreticulin in the antiviral response of Litopenaeus vannamei against white spot syndrome virus. Journal of Invertebrate Pathology 211 (cited 0 times)
2
Sirisarn W., Mordmuang A., Sukpondma Y., Obchoei S., Saeheng S., 2025. Sequential Solvent Extraction of Caesalpinia pulcherrima Yellow Flowers Reveals Potent Antioxidant, Antimicrobial, and Anticancer Activities Against Various Human Cancer Cell Lines. Trends in Sciences 22(4) (cited 0 times)
3
Meethong M., Ekchaweng K., Obchoei S., Jakkawanpitak C., Runsaeng P., 2025. The acidic latex protein from Hevea brasiliensis serves as an anionic antimicrobial peptide. PeerJ 13(4) (cited 0 times)
4
Sathitruangsak C., Pattarapuntakul T., Kaewdech A., Thongkan T., Prisutkul A., Thongwatchara P., Sriplung H., Kongkamol C., Kanokwiroon K., Obchoei S., Sripongpun P., 2024. Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand. Cancer Medicine 13(24) (cited 0 times)
5
Kidoikhammouan S., Lert-Itthiporn W., Deenonpoe R., Saengboonmee C., Obchoei S., Wongkham S., Seubwai W., 2024. Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma. Anticancer Research 44(12): 5393-5404. (cited 1 times)
6
Pratummanee K., Kerdkumthong K., Roytrakul S., Tantimetta P., Runsaeng P., Saeheng S., Obchoei S., 2024. Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells. Molecular Medicine Reports 30(5) (cited 1 times)
7
Pantong W., Somsap O.A., Kamnate A., Ekchaweng K., Obchoei S., Saeheng S., 2024. Analyzing the Antibacterial, Anticancer, and Antioxidant Qualities of the Stink Bean (Parkia Speciosa) by Various Extraction Techniques. Trends in Sciences 21(9) (cited 1 times)
8
Kerdkumthong K., Roytrakul S., Songsurin K., Pratummanee K., Runsaeng P., Obchoei S., 2024. Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma. Biomolecules 14(8) (cited 2 times)
9
Kerdkumthong K., Nanarong S., Roytrakul S., Pitakpornpreecha T., Tantimetta P., Runsaeng P., Obchoei S., 2024. Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells. PLoS ONE 19(6 June) (cited 1 times)
10
Kerdkumthong K., Chanket W., Runsaeng P., Nanarong S., Songsurin K., Tantimetta P., Angsuthanasombat C., Aroonkesorn A., Obchoei S., 2024. Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines. Probiotics and Antimicrobial Proteins 16(3): 713-725. (cited 5 times)
Access all results for your search in Scopus (Author ID: 35503734500)
Content provided by Scopus.

Publication

ฐานข้อมูลคณะวิทยาศาสตร์

1
Kidoikhammouan, S., Lert-itthiporn, W., Deenonpoe, R., Saengboonmee, C., Obchoei, S., Wongkham, S., & Seubwai, W. (2024). Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma. Anticancer Research, 44(12), 5393-5404.
2
Kerdkumthong , K., Chanket , W., Runsaeng, P., Nanarong , S., Songsurin , K., Tantimetta , P., Angsuthanasombat , C., Aroonkesorn, A., & Obchoei, S. (2024). Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines. Probiotics And Antimicrobial Proteins, 16(3), 713-725.
3
Sathitruangsak, C., Pattarapuntakul, T., Kaewdech, A., Thongkan, T., Prisutkul, A., Thongwatchara, P., Sriplung, H., Kongkamol, C., Kanokwiroon, K., Obchoei, S., & Sripongpun, P. (2024). Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand (SCIE). Cancer Medicine, 13(24), Article number e70491.
4
Pantong, W., Somsap, O., Ekchaweng, K., Obchoei, S., & Saeheng, S. (2024). Analyzing the Antibacterial, Anticancer, and Antioxidant Qualities of the Stink Bean (Parkia Speciosa) by Various Extraction Techniques. Trends In Sciences, 21(9), Article number 7994.
5
Kerdkumthong, K., Roytrakul, S., Songsurin, K., & Obchoei, S. (2024). Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma (SCIE). Biomolecules, 14(8), Biomolecules.
6
Pratummanee, K., Kerdkumthong, K., Roytrakul, S., Tantimetta, P., Runsaeng, P., Saeheng, S., & Obchoei, S. (2024). Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells (SCIE). Molecular Medicine Reports, 30(5), Article number 198.
7
Kerdkumthong, K., Nanarong, S., Roytrakul, S., Pitakpornpreecha, T., Tantimetta, P., Runsaeng, P., & Obchoei, S. (2024). Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells (SCIE). Plos One, 19(6), Article number e0306060.
8
Kerdkumthong, K., Chanket, W., Runsaeng, P., Nanarong, S., Songsurin, K., Tantimetta, P., Angsuthanasombat, C., Aroonkesorn, A., & Obchoei, S. (2023). Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines (SCIE). Probiotics And Antimicrobial Proteins, 00, 00.
9
Saengboonmee, C., Obchoei, S., Sawanyawisuth, K., & Wongkham, S. (2023). Revision of potential prognostic markers of cholangiocarcinoma for clinical practice (SCIE). Expert Review Of Anticancer Therapy, 23(5), 517-530.
10
Obchoei, S., Detarya, M., Boonnate, P., Saranaruk, P., Vaeteewoottacharn, K., Mahalapbutr, P., Okada, S., & Wongkham, S. (2022). Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor. Asian Pacific Journal Of Cancer Prevention : Apjcp, 23(10), 3379 - 3386.
11
Madsari, N., Maskaew, S., Obchoei, S., Kwankaew, P., Senghoi, W., Utarabhand, P., & Runsaeng, P. (2022). Determination of the efficacy of using a serine protease gene as a DNA vaccine to protect against Vibrio parahaemolyticus infection in Litopenaeus vannamei (SCIE) . Developmental And Comparative Immunology, 135, Article number 104459.
12
U Kotepui, K., Obchoei, S., Vaeteewoottacharn, K., Okada, S., Wongkham, S., & Sawanyawisuth, K. (2022). Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma. Asian Pacific Journal Of Cancer Prevention, 23(2), 715 - 721.
13
Klinhom-on, N., Seubwai, W., Sawanyawisuth, K., Obchoei, S., Mahalapbutr, P., & Wongkham, S. (2021). FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase (SCIE). Life Sciences, 286, Article number 120072.
14
Dana, P., Saisomboon, S., Kariya, R., Okada, S., Obchoei, S., Sawanyawisuth, K., Wongkham, C., Pairojkul, C., Wongkham, S., & Vaeteewoottacharn, K. (2020). CD147 Augmented Monocarboxylate transporter-1/4 Expression Through Modulation of the Akt-FoxO3-NF-κB Pathway Promotes Cholangiocarcinoma Migration and Invasion. Cellular Oncology, 43(2), 211-222.